Bayer Upbeat, Plans Chemicals IPO by 2016

March 11, 2015 7:57 AM

12 0

Bayer Upbeat, Plans Chemicals IPO by 2016

FRANKFURT--Germany’s Bayer AG is forecasting strong sales and earnings growth at its health-care division in the next three years, pegging the yearly sales potential of its top drugs at €7.5 billion ($8 billion).

Bayer said it aims to increase health-care revenue by an average of about 6% a year through 2017 to more than €25 billion.

Also read: Samsung Electronics says reviewing shift to holding company structure

Read more

To category page

Loading...